Literature DB >> 10658974

NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals.

A B Bakker1, J Wu, J H Phillips, L L Lanier.   

Abstract

A delicate balance between positive and negative signals regulates NK cell effector function. Activation of NK cells may be initiated by the triggering of multiple adhesion or costimulatory molecules, and can be counterbalanced by inhibitory signals induced by receptors for MHC class I. A common pathway of inhibitory signaling is provided by immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in the cytoplasmic domains of these receptors which mediate the recruitment of SH2 domain-bearing tyrosine phosphate-1 (SHP-1). In contrast to the extensive progress that has been made regarding the negative regulation of NK cell function, our knowledge of the signals that activate NK cells is still poor. Recent studies of the activating receptor complexes have shed new light on the induction of NK cell effector function. Several NK receptors using novel adaptors with immunoreceptor tyrosine-based activation motifs (ITAMs) and with PI 3-kinase recruiting motifs have been implicated in NK cell stimulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658974     DOI: 10.1016/s0198-8859(99)00160-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  24 in total

1.  mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.

Authors:  Z Yu; M Maoui; L Wu; D Banville; S Shen
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

2.  Effect of 70-kDa heat shock protein on interferon-gamma production by human natural killers.

Authors:  E I Kovalenko; P A Vlaskin; L M Kanevskii; Y I Strel'nikova; A M Sapozhnikov
Journal:  Dokl Biol Sci       Date:  2006 Jan-Feb

3.  Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge.

Authors:  Neil Taylor; Karen McConachie; Karen McConnachie; Claudia Calder; Rosemary Dawson; Andrew Dick; Jonathon D Sedgwick; Janet Liversidge
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

4.  Identification and characterization of a spliced C-type lectin-like gene encoded by rat cytomegalovirus.

Authors:  S Voigt; G R Sandford; L Ding; W H Burns
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo.

Authors:  A Cerwenka; J L Baron; L L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

6.  VASP Regulates NK Cell Lytic Granule Convergence.

Authors:  Katelynn M Wilton; Daniel D Billadeau
Journal:  J Immunol       Date:  2018-10-03       Impact factor: 5.422

7.  NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Authors:  Jeyarani Regunathan; Yuhong Chen; Demin Wang; Subramaniam Malarkannan
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

8.  Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.

Authors:  Kazuhiro Ohmi; David S Greenberg; Kavitha S Rajavel; Sergey Ryazantsev; Hong Hua Li; Elizabeth F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

Review 9.  Natural killer cell immunotherapy for cancer: a new hope.

Authors:  S Srivastava; A Lundqvist; R W Childs
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

10.  Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

Authors:  Liat Binyamin; R Katherine Alpaugh; Tracey L Hughes; Charles T Lutz; Kerry S Campbell; Louis M Weiner
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.